Clin2
NCT07392125Possibly a fitNot yet recruiting

Vaping cessation study for adults using nicotine e-cigarettes

Vaping Cessation

Treatments studied

Part of Lungs & breathing clinical trials.

This study tests a new medicine called cytisinicline to help adults stop vaping nicotine. It also includes counseling to support quitting. If you've tried to quit vaping before and want to try a medication, this might be a good fit.

Summary written for real people, not researchers, by Clin2.

Phase
Phase 3
Enrollment
800 people
Ages
18 years and older
Study type
Interventional

Who can take part

  • You are 18 years or older.
  • You vape nicotine every day and have tried to quit at least once before.
  • You are willing to set a quit date within 2 weeks of starting the study.
  • You are willing to join counseling sessions to help you quit.
  • You do not smoke cigarettes or use other tobacco products like pouches or cigars.
  • You have not used cannabis (marijuana) in the last 4 weeks and won't during the study.

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT07274475Not yet recruiting
Using e-cigarettes or cytisine to help reduce smoking

This study looks at whether using e-cigarettes (vapes) or a quit-smoking medicine called cytisine can help people cut down or stop smoking. It is a 12-month program that provides support to see which approach might work better for harm reduction.

NCT06474299Recruiting· Phase 4
Quitting cigarettes and vaping with medication support

This study tests whether using two quit-smoking medicines together helps people stop both cigarettes and vaping. It may offer extra support to help you quit.

Madison, Wisconsin
NCT07786896Not yet recruiting· Phase 4
Quitting vaping with nicotine replacement therapy

This study tests whether nicotine replacement therapy (like patches or gum) can help people who regularly vape nicotine to quit. It aims to understand dependence and support quitting efforts.

Greenville, North Carolina
NCT07040566Recruiting· Phase 2
Varenicline to help stop vaping

This trial tests whether varenicline, a medicine that reduces cravings, can help people quit using e-cigarettes that contain nicotine. You must be a daily nicotine vaper and live in Connecticut or South Carolina.

New Haven, Connecticut
NCT06617312Recruiting· Phase 2
Cytisinicline and brain response to smoking cues

This study tests how a medicine called cytisinicline (similar to a plant-based stop-smoking aid) affects brain activity when you see or think about smoking. It may help researchers understand how the medicine works, even if you aren't ready to quit right now.

Los Angeles, California
NCT06688539Recruiting· Phase 4
Quitting e-cigarettes in adults who also use cannabis

This trial tests if varenicline, a stop-smoking medication, can help people ages 18 to 40 quit e-cigarettes while also using cannabis. It's designed for regular e-cigarette users who want to quit and who use cannabis at least 10 days per month.

Charleston, South Carolina

Hear when a new Vaping Cessation trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.